MATTER launches first Paratus Digital Health Hub Readiness Accelerator as part of BARDA Accelerator Network

The accelerator seeks next-generation digital health solutions supporting preparedness and response to health security threats

Zymo Research & BluMaiden Biosciences Announce Partnership to Provide Clinical Trial Analytics and Reporting Services to the Pharmaceutical Sector

This press release announces the partnership between Zymo Research and BluMaiden Biosciences to provide end-to-end clinical trial analytics and reporting services based on the human microbiome. We believe this development will be of significant interest to your audience, particularly those working in the pharmaceutical sector. The press release highlights how the new joint service will cover every stage of human microbiome analysis, including fit-for-purpose sample collection, nucleic acid purification, next-generation sequencing, sophisticated bioinformatics data analysis, and detailed clinical trial reporting. This service is designed to be applicable across entire trial cohorts and can be applied to a broad range of disease indications and intervention modalities, making it especially valuable for researchers and professionals in the pharma industry with the aim of enhancing therapeutic efficacy and commercial lifespan.

Sphere Fluidics announces Cyto-Mine Chroma to accelerate and streamline workflows across expanded applications in biotherapeutic discovery and development

Sphere Fluidics has introduced Cyto-Mine Chroma – the second generation of its award-winning, flagship Cyto-Mine single cell analysis and isolation platform. With the upgrade to a four-color laser and detector system, Chroma offers enhanced capabilities to further maximise the efficiency and precision of single-cell functional analysis workflows. By accelerating the early selection of superior candidate cells, it supports project timelines to be reduced from months to weeks, and minimising effort and cost.

Vaxess Receives National Institutes of Health Grant to Explore Administering Type 2 Diabetes Treatment via the MIMIX™ Transdermal Patch Platform

The National Institute of Diabetes and Digestive and Kidney Diseases Awards Vaxess SBIR Phase I Funding to Test Company’s MIMIX Transdermal Patch Platform in Administering GLP-1 RA Therapies

VieCure Secures $45 Million Financing to Accelerate Adoption of First AI-Enabled Community Oncology Care Platform

VieCure Inc. announced the completion of a $45 million financing led by Northpond Ventures and the appointment of industry veteran Richard Daly as chairman of the board of directors.

Recipharm and Exela announce exclusive strategic alliance

CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review

CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest addition to its enterprise software platform

ResultsCX Named 'Major Contender' in Everest Group's Customer Experience Management Services PEAK Matrix® Assessment 2024, Americas

ResultsCX, a provider of Customer Experience Management (CXM) services to leading global companies including Fortune 100 and 500 firms, today announced it was honored as a Major Contender in Everest Group’s Customer Experience Management (CXM) Services PEAK Matrix® Assessment (Americas region) for the fourth consecutive year. This recognition underlines the company’s ongoing expansion and commitment to supporting organizations across industries in optimizing consumer experience (CX) and driving growth.

CRDSA Announces Publication of Standards for Clinical Trial Data Reuse

The Clinical Research Data Sharing Alliance (CRDSA), a multi-stakeholder consortium that serves the clinical research data ecosystem, has announced the publication of two new standards; the Standard for Sharing Clinical Study Data and the Standard for Secondary Analysis of Clinical Study Data. CRDSA developed these standards in response to common challenges faced by both data contributors and researchers. These new standards aim to facilitate the responsible sharing and use of anonymized individual patient data from clinical studies to support the research community and accelerate the discovery and delivery of new therapies to patients.

Cytiva and Pear Bio empower personalized cancer medicine with innovative single-cell technology

Takara Bio Europe unveils new large-scale NGS profiling system and chemistries

Takara Bio Europe has announced the launch of the Shasta™ Single-Cell System, a high-throughput NGS solution enabling novel biomarker discovery in oncology research, at the 2024 Human Cell Atlas General Meeting. This comprehensive system combines well-validated chemistries with user-friendly bioinformatics tools, allowing researchers to mine more genomic and transcriptomic information from a much greater number of cells than previously possible, all while reducing both time and costs. The Shasta system and Shasta Whole-Genome Amplification (WGA) Kit increases throughput by processing up to 1,500 cells per run, compared to current technologies which are limited to 384 single cells, while also enabling the detection of single-cell level CNV events via shallow sequencing. Its ability to detect RNA biotypes, such as non-polyadenylated lncRNAs, otherwise missed by current droplet-based technologies represents a significant advancement over traditional plate-based full-length RNA-seq and high-throughput mRNA-seq methods.

Phastar Announced as 2024 Scrip Award Finalist for Best Contract Research Organization – Specialist Provider

Phastar’s Data Analytics and Visualization Portal and commitment to high ESG standards secures shortlist spot at the 20th Anniversary Scrip Awards

Duke Street Bio Granted Approval by European Medicines Agency to Launch Next-Generation PARP1-Selective Inhibitor Trial

Duke Street Bio Ltd has announced that the European Medicines Agency (EMA) has granted approval to commence a clinical trial for its highly-selective PARP1 inhibitor, DSB2455.

Endor Labs Brings Aboard Cybersecurity Veteran Karl Mattson as Chief Information Security Officer

Endor Labs, the leader in open source software security, today announced that industry veteran Karl Mattson has been named as the company’s first Chief Information Security Officer (CISO).

TOSS Machine Components Highlights PIREG®-545 Panel Mounted Impulse Heat Seal Controller for Biotechnology and Pharmaceutical Applications

The PIREG-545 impulse heat seal controller offers significant advantages in the medical and pharmaceutical markets. Its quick and precise control offers repeatable and consistent heat seal results critical for processes in need of validation as many life science applications demand. The PIREG-545 enhances quality control and compliance to industry standards.

Integrated DNA Technologies Unveils New Lymphoma Panel to Enhance Blood Cancer Research

Watson-Marlow Fluid Technology Solutions showcases recently launched WMArchitect™ single-use solutions along with a range of pumps and hoses at CPHI Milan 2024

Watson-Marlow Fluid Technology Solutions (WMFTS) will display a range of peristaltic pumps and associated fluid path technologies for the life sciences industry during CPHI Milan 2024 at Fiera Milano on 8th – 10th October.

MATTER Selected to Lead the Digital Health Hub in the Next Generation of the BARDA Accelerator Network

The Biomedical Advanced Research and Development Authority (BARDA) has selected MATTER to lead the new Digital Health Hub as part of the BARDA Accelerator Network. The hub, called Paratus, will support the development of next-gen digital health technologies to address health security threats.

Zymo Research Stands by Its Innovative cfDNA Technology in Response to Qiagen’s Lawsuit

Zymo Research Corporation, a leader in innovative life science solutions, acknowledges the patent infringement lawsuit filed by Qiagen GmbH on August 20, 2024, at the US District Court for the Central District of California regarding its MAGicBead cfDNA isolation technology. Zymo Research respects intellectual property rights and is confident that this technology represents a significant advancement in nucleic acid purification.

CDC Awards Grant to NAFC, Phreesia and Health.Equity.Outcomes. to Tackle Public Health Challenge of Urinary Incontinence

Phreesia, the National Association For Continence (NAFC), Health.Equity.Outcomes. and Christina Escobar, MD, at New York University, are proud to announce that the U.S. Centers for Disease Control and Prevention (CDC) has awarded a grant for a joint project focused on combating the public health challenge of urinary incontinence in women.